Results 151 to 160 of about 15,815 (221)

Efficacy and Safety of the Selective, Brain-Penetrant P2X7 Receptor Antagonist JNJ-55308942 (Zanvipixant) in Bipolar Depression: A Phase 2a Study. [PDF]

open access: yesBiol Psychiatry Glob Open Sci
Palmer JA   +10 more
europepmc   +1 more source

Activity of Peptides Modulating the Action of p2x Receptors: Focus on the p2x7 Receptor. [PDF]

open access: yesPharmaceuticals (Basel)
De Souza Oliveira Carneiro JA   +3 more
europepmc   +1 more source

Therapeutic potential of P2X7 receptor in retinal diseases. [PDF]

open access: yesPurinergic Signal
Wen M   +6 more
europepmc   +1 more source

A Holistic Approach to Identifying a Positron Emission Tomography (PET) Tracer Candidate for In Vivo Imaging of Purinergic P2X7 Receptor in Neuroinflammation. [PDF]

open access: yesACS Pharmacol Transl Sci
Ghafir El Idrissi I   +23 more
europepmc   +1 more source

Trends in Research on the P2X7 Receptor: A Bibliometric and Visualization Analysis. [PDF]

open access: yesJ Inflamm Res
Ren C   +8 more
europepmc   +1 more source

Type II Cells in the Human Carotid Body Display P2X7 Receptor and Pannexin-1 Immunoreactivity. [PDF]

open access: yesBiomolecules
Anache M   +10 more
europepmc   +1 more source

Blockage of P2X7 receptor activation attenuated bone loss in ligature-induced model of periodontitis in rats. [PDF]

open access: yesPurinergic Signal
Linhares N   +14 more
europepmc   +1 more source

Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss. [PDF]

open access: yesAlzheimers Res Ther
Maschio CA   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy